Sandeep Bodduluri1, Surya P Bhatt2,3,4, Eric A Hoffman1,5, John D Newell1,5, Carlos H Martinez6, Mark T Dransfield2,3,4, Meilan K Han6, Joseph M Reinhardt1. 1. Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, USA. 2. Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. 3. UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. 4. UAB Lung Imaging Core, University of Alabama at Birmingham, Birmingham, Alabama, USA. 5. Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 6. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Abstract
BACKGROUND: Traditional metrics of lung disease such as those derived from spirometry and static single-volume CT images are used to explain respiratory morbidity in patients with COPD, but are insufficient. We hypothesised that the mean Jacobian determinant, a measure of local lung expansion and contraction with respiration, would contribute independently to clinically relevant functional outcomes. METHODS: We applied image registration techniques to paired inspiratory-expiratory CT scans and derived the Jacobian determinant of the deformation field between the two lung volumes to map local volume change with respiration. We analysed 490 participants with COPD with multivariable regression models to assess strengths of association between traditional CT metrics of disease and the Jacobian determinant with respiratory morbidity including dyspnoea (modified Medical Research Council), St Georges Respiratory Questionnaire (SGRQ) score, 6-min walk distance (6MWD) and the Body Mass Index, Airflow Obstruction, Dyspnoea and Exercise Capacity (BODE) index, as well as all-cause mortality. RESULTS: The Jacobian determinant was significantly associated with SGRQ (adjusted regression coefficient β=-11.75,95% CI -21.6 to -1.7; p=0.020), and with 6MWD (β=321.15, 95% CI 134.1 to 508.1; p<0.001), independent of age, sex, race, body mass index, FEV1, smoking pack-years, CT emphysema, CT gas trapping, airway wall thickness and CT scanner type. The mean Jacobian determinant was also independently associated with the BODE index (β=-0.41, 95% CI -0.80 to -0.02; p=0.039) and mortality on follow-up (adjusted HR=4.26, 95% CI 0.93 to 19.23; p=0.064). CONCLUSIONS: Biomechanical metrics representing local lung expansion and contraction improve prediction of respiratory morbidity and mortality and offer additional prognostic information beyond traditional measures of lung function and static single-volume CT metrics. TRIAL REGISTRATION NUMBER: NCT00608764; Post-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: Traditional metrics of lung disease such as those derived from spirometry and static single-volume CT images are used to explain respiratory morbidity in patients with COPD, but are insufficient. We hypothesised that the mean Jacobian determinant, a measure of local lung expansion and contraction with respiration, would contribute independently to clinically relevant functional outcomes. METHODS: We applied image registration techniques to paired inspiratory-expiratory CT scans and derived the Jacobian determinant of the deformation field between the two lung volumes to map local volume change with respiration. We analysed 490 participants with COPD with multivariable regression models to assess strengths of association between traditional CT metrics of disease and the Jacobian determinant with respiratory morbidity including dyspnoea (modified Medical Research Council), St Georges Respiratory Questionnaire (SGRQ) score, 6-min walk distance (6MWD) and the Body Mass Index, Airflow Obstruction, Dyspnoea and Exercise Capacity (BODE) index, as well as all-cause mortality. RESULTS: The Jacobian determinant was significantly associated with SGRQ (adjusted regression coefficient β=-11.75,95% CI -21.6 to -1.7; p=0.020), and with 6MWD (β=321.15, 95% CI 134.1 to 508.1; p<0.001), independent of age, sex, race, body mass index, FEV1, smoking pack-years, CT emphysema, CT gas trapping, airway wall thickness and CT scanner type. The mean Jacobian determinant was also independently associated with the BODE index (β=-0.41, 95% CI -0.80 to -0.02; p=0.039) and mortality on follow-up (adjusted HR=4.26, 95% CI 0.93 to 19.23; p=0.064). CONCLUSIONS: Biomechanical metrics representing local lung expansion and contraction improve prediction of respiratory morbidity and mortality and offer additional prognostic information beyond traditional measures of lung function and static single-volume CT metrics. TRIAL REGISTRATION NUMBER: NCT00608764; Post-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Kai Ding; Kunlin Cao; Matthew K Fuld; Kaifang Du; Gary E Christensen; Eric A Hoffman; Joseph M Reinhardt Journal: Med Phys Date: 2012-08 Impact factor: 4.071
Authors: Nicola Sverzellati; David A Lynch; Massimo Pistolesi; Hans-Ulrich Kauczor; P A Grenier; C Wilson; J D Crapo Journal: Chronic Obstr Pulm Dis Date: 2014
Authors: Carlos H Martinez; Ya-Hong Chen; Phillip M Westgate; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Barry J Make; Ella A Kazerooni; David A Lynch; Nathaniel Marchetti; George R Washko; Fernando J Martinez; Meilan K Han Journal: Thorax Date: 2012-05 Impact factor: 9.139
Authors: Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman Journal: Thorax Date: 2013-03-23 Impact factor: 9.139
Authors: Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko Journal: Am J Respir Crit Care Med Date: 2013-11-01 Impact factor: 21.405
Authors: Wassim W Labaki; Tian Gu; Susan Murray; Charles R Hatt; Craig J Galbán; Brian D Ross; Carlos H Martinez; Jeffrey L Curtis; Eric A Hoffman; Esther Pompe; David A Lynch; Ella A Kazerooni; Fernando J Martinez; MeiLan K Han Journal: Acad Radiol Date: 2018-07-26 Impact factor: 3.173
Authors: Wassim W Labaki; Tian Gu; Susan Murray; Charles R Hatt; Craig J Galbán; Brian D Ross; Carlos H Martinez; Jeffrey L Curtis; Eric A Hoffman; Esther Pompe; David A Lynch; Ella A Kazerooni; Fernando J Martinez; MeiLan K Han Journal: Acad Radiol Date: 2019-02-18 Impact factor: 3.173
Authors: Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2022-02-01 Impact factor: 21.405
Authors: Surya P Bhatt; George R Washko; Eric A Hoffman; John D Newell; Sandeep Bodduluri; Alejandro A Diaz; Craig J Galban; Edwin K Silverman; Raúl San José Estépar; David A Lynch Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405